Beta-lactam and beta-lactamase inhibitor combinations: Optimizing PK/PD

November 17, 2021

Practice and evidence around optimization of beta-lactam pharmacokinetics and pharmacodynamics changes very often. The barriers of lack of resources and experience on the data and knowledge will be removed through a deep dive into how best to leverage the most current pharmacokinetic and pharmacodynamic data to improve patient outcomes.

Target Audience

  • Pharmacists
  • Pharmacy technicians

Learning Objectives

Pharmacist earning objectives

  1. Explain research methodologies utilized to assess treatment strategies for beta-lactams
  2. Describe the pharmacokinetic and pharmacodynamic (PK/PD) goals of beta-lactams
  3. Review contemporary clinical data supporting beta-lactam therapeutic optimization methods
  4. Describe typical population variability seen in beta-lactam PK
  5. Identify strategies to improve PK/PD goals
  6. Calculate beta-lactam PK/PD metrics for an individual patient

Pharmacy technician learning objectives

  1. Describe the pharmacokinetic and pharmacodynamic (PK/PD) goals of beta-lactams
  2. Identify strategies to improve PK/PD goals

Additional Information

AttachmentSize
PDF icon Helpful Tips for Users - Vizient CE System.pdf134.81 KB
File Information for CE Credit - Beta-lactam and Beta-lactamase inhibitor combinations.docx125.61 KB
Course summary
Available credit: 
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Technician
  • 1.00 General CE - Attendance
Course opens: 
10/17/2021
Course expires: 
01/03/2022
Event starts: 
11/17/2021 - 1:00pm CST
Event ends: 
11/17/2021 - 2:00pm CST
Add to calendar: 
Live via webinar
United States
Relevant financial relationships: The presenter will discuss off-label and investigative use of drugs.
 
The presenter has disclosed the following relevant financial relationships:
  • Received consulting fee from Takeda
  • Grant investigator/consulting fee from Nevakar
  • Consulting fee/grant (in process) from SuperTrans Medical
  • Consulting fee from AbbVie.
Planning committee members
Jackie Stokes, BS
Manager, Pharmacy Program
Vizient, Inc.
 
Gretchen Brummel, PharmD, BCPS
Consulting Solutions Director
Vizient, Inc.
 
Course reviewer
Gretchen Brummel, PharmD, BCPS
Consulting Solutions Director
Vizient, Inc.
 
Presenter
Marc H. Scheetz, PharmD, MSc, FCCP, BCPS AQ-ID
Infectious Diseases Pharmacist
Northwestern Medicine Department of Pharmacy
Joint Accreditation Statement:
 
In support of improving patient care, Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
____________________________________________
 
Designation Statement:
 
PHARMACY
Vizient, Inc. designates this activity for a maximum of 1.00 ACPE credit hours.
Universal Activity Number: JA0006103-0000-21-280-L01-P
Universal Activity Number: JA0006103-0000-21-280-L01-T
CEU
Vizient, Inc. will award CEUs to each participant who successfully completes this program. The CEU is a nationally recognized unit of measure for continuing education and training programs that meet certain criteria (1 contact hour = 0.1 CEU).

Available Credit

  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Technician
  • 1.00 General CE - Attendance
Please login or register to take this course.